Feedback / Questions
Habeo Cell Therapy (ECCS-50) - Plus Therap
Cytori Therapeutics: Annual Shareholders' Meeting
(Cytori)
-
Aug 30, 2013 -
Anticipated data from P2 ATHENA trial in US for refractory heart failure in Q2 2014
Anticipated P2 data
•
Acute Coronary Syndrome
http://ir.cytori.com/files/doc_presentations/2013/Annual%20Meeting_08282013.pdf
Aug 30, 2013
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.